Skip to main content
. 2022 May 7;17:181. doi: 10.1186/s13023-022-02337-2

Fig. 6.

Fig. 6

Multi-stakeholders involvement in providing data to advance diagnostics and therapies for rare disease patients. This graphic shows the requirement for different type of data originating from multiple stakeholder sources (patients, academic research, industry and regulators) and the need to share this information to efficiently advance the development of diagnoses and therapies